id todo:paper_03405354_v249_n4_p375_Correale
record_format dspace
spelling todo:paper_03405354_v249_n4_p375_Correale2023-10-03T15:25:36Z Oligoclonal bands and antibody responses in Multiple Sclerosis Correale, J. De los Milagros Bassani Molinas, M. Antibodies Autoimmunity B cells Multiple Sclerosis Oligoclonal bands antiidiotypic antibody autoantibody autoantigen corticosteroid corticotropin immunoglobulin A immunoglobulin D immunoglobulin G immunoglobulin light chain immunoglobulin M myelin antibody response antigen recognition cellular immunity cerebrospinal fluid analysis demyelination disease course human humoral immunity immune response immunoblotting immunoglobulin production laboratory test multiple sclerosis myelin sheath nonhuman pathogenesis priority journal protein analysis remyelinization review T lymphocyte activation Animals Antibody Formation Humans Immunoglobulin G Immunoglobulins Multiple Sclerosis Oligoclonal Bands Multiple Sclerosis (MS) is an inflammatory disease of the Central Nervous System with multifocal areas of demyelination. Although its etiology and pathogenesis remain controversial, several lines of evidence indicate that MS is mediated by a misdirected immune response against one or several myelin proteins. The involvement of diverse leukocyte subsets and their products in MS is still the subject of considerable debate. The emphasis on T cells has derived mainly from the detection of activated T cells in MS plaques and analogies with animal models of MS. Because of these observations cell-mediated immunity has dominated the research field of MS to this day. However, in recent years the role of B cells, plasma cells and immunoglobulins in MS have been re-examined, and current findings indicate that humoral immunity also plays a major role in disease pathogenesis. B cells and their products could exert several potential effects during the course of MS. Firstly, autoantibodies against specific myelin antigens could mediate damage to myelin membranes. Secondly, some studies suggest that natural autoantibodies could enhance remyelination. Thirdly, antibodies directed against myelin components can participate in anti-idiotypic networks, which may regulate the course of MS. Increased intrathecal immunoglobulin synthesis reflected by raised IgG indices and an oligoclonal pattern is the most common abnormality detected in MS patients. The introduction of more sensitive procedures for protein detection has allowed demonstrating oligoclonal bands (OCBs) in up to 95% of patients with clinically definite MS. Although the presence of OCBs in CSF of MS patients is now well established as a sensitive laboratory test to support the clinical diagnosis, OCBs may be present in other disorders, including those not directly related to infection or abnormal immune response. Nevertheless, the pathogenesis of OCBs in MS is still obscure, and despite extensive research their antigenic target(s) have yet to be established. Therefore, a critical task is to identify the specificity of such target(s), thus providing significant clues about MS etiology. For this purpose, novel molecular immunologic strategies have been recently developed to offer alternative approaches to identify putative antigens recognized by antibodies present in MS patients. The elucidation of the mechanisms and target(s) responsible for the onset of MS has obvious implications for the further development of specific therapies. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03405354_v249_n4_p375_Correale
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antibodies
Autoimmunity
B cells
Multiple Sclerosis
Oligoclonal bands
antiidiotypic antibody
autoantibody
autoantigen
corticosteroid
corticotropin
immunoglobulin A
immunoglobulin D
immunoglobulin G
immunoglobulin light chain
immunoglobulin M
myelin
antibody response
antigen recognition
cellular immunity
cerebrospinal fluid analysis
demyelination
disease course
human
humoral immunity
immune response
immunoblotting
immunoglobulin production
laboratory test
multiple sclerosis
myelin sheath
nonhuman
pathogenesis
priority journal
protein analysis
remyelinization
review
T lymphocyte activation
Animals
Antibody Formation
Humans
Immunoglobulin G
Immunoglobulins
Multiple Sclerosis
Oligoclonal Bands
spellingShingle Antibodies
Autoimmunity
B cells
Multiple Sclerosis
Oligoclonal bands
antiidiotypic antibody
autoantibody
autoantigen
corticosteroid
corticotropin
immunoglobulin A
immunoglobulin D
immunoglobulin G
immunoglobulin light chain
immunoglobulin M
myelin
antibody response
antigen recognition
cellular immunity
cerebrospinal fluid analysis
demyelination
disease course
human
humoral immunity
immune response
immunoblotting
immunoglobulin production
laboratory test
multiple sclerosis
myelin sheath
nonhuman
pathogenesis
priority journal
protein analysis
remyelinization
review
T lymphocyte activation
Animals
Antibody Formation
Humans
Immunoglobulin G
Immunoglobulins
Multiple Sclerosis
Oligoclonal Bands
Correale, J.
De los Milagros Bassani Molinas, M.
Oligoclonal bands and antibody responses in Multiple Sclerosis
topic_facet Antibodies
Autoimmunity
B cells
Multiple Sclerosis
Oligoclonal bands
antiidiotypic antibody
autoantibody
autoantigen
corticosteroid
corticotropin
immunoglobulin A
immunoglobulin D
immunoglobulin G
immunoglobulin light chain
immunoglobulin M
myelin
antibody response
antigen recognition
cellular immunity
cerebrospinal fluid analysis
demyelination
disease course
human
humoral immunity
immune response
immunoblotting
immunoglobulin production
laboratory test
multiple sclerosis
myelin sheath
nonhuman
pathogenesis
priority journal
protein analysis
remyelinization
review
T lymphocyte activation
Animals
Antibody Formation
Humans
Immunoglobulin G
Immunoglobulins
Multiple Sclerosis
Oligoclonal Bands
description Multiple Sclerosis (MS) is an inflammatory disease of the Central Nervous System with multifocal areas of demyelination. Although its etiology and pathogenesis remain controversial, several lines of evidence indicate that MS is mediated by a misdirected immune response against one or several myelin proteins. The involvement of diverse leukocyte subsets and their products in MS is still the subject of considerable debate. The emphasis on T cells has derived mainly from the detection of activated T cells in MS plaques and analogies with animal models of MS. Because of these observations cell-mediated immunity has dominated the research field of MS to this day. However, in recent years the role of B cells, plasma cells and immunoglobulins in MS have been re-examined, and current findings indicate that humoral immunity also plays a major role in disease pathogenesis. B cells and their products could exert several potential effects during the course of MS. Firstly, autoantibodies against specific myelin antigens could mediate damage to myelin membranes. Secondly, some studies suggest that natural autoantibodies could enhance remyelination. Thirdly, antibodies directed against myelin components can participate in anti-idiotypic networks, which may regulate the course of MS. Increased intrathecal immunoglobulin synthesis reflected by raised IgG indices and an oligoclonal pattern is the most common abnormality detected in MS patients. The introduction of more sensitive procedures for protein detection has allowed demonstrating oligoclonal bands (OCBs) in up to 95% of patients with clinically definite MS. Although the presence of OCBs in CSF of MS patients is now well established as a sensitive laboratory test to support the clinical diagnosis, OCBs may be present in other disorders, including those not directly related to infection or abnormal immune response. Nevertheless, the pathogenesis of OCBs in MS is still obscure, and despite extensive research their antigenic target(s) have yet to be established. Therefore, a critical task is to identify the specificity of such target(s), thus providing significant clues about MS etiology. For this purpose, novel molecular immunologic strategies have been recently developed to offer alternative approaches to identify putative antigens recognized by antibodies present in MS patients. The elucidation of the mechanisms and target(s) responsible for the onset of MS has obvious implications for the further development of specific therapies.
format JOUR
author Correale, J.
De los Milagros Bassani Molinas, M.
author_facet Correale, J.
De los Milagros Bassani Molinas, M.
author_sort Correale, J.
title Oligoclonal bands and antibody responses in Multiple Sclerosis
title_short Oligoclonal bands and antibody responses in Multiple Sclerosis
title_full Oligoclonal bands and antibody responses in Multiple Sclerosis
title_fullStr Oligoclonal bands and antibody responses in Multiple Sclerosis
title_full_unstemmed Oligoclonal bands and antibody responses in Multiple Sclerosis
title_sort oligoclonal bands and antibody responses in multiple sclerosis
url http://hdl.handle.net/20.500.12110/paper_03405354_v249_n4_p375_Correale
work_keys_str_mv AT correalej oligoclonalbandsandantibodyresponsesinmultiplesclerosis
AT delosmilagrosbassanimolinasm oligoclonalbandsandantibodyresponsesinmultiplesclerosis
_version_ 1807322346345725952